Rachel King

(Ms. Rachel King)

Currently holds positions in Novavax Inc and GlycoMimetics Inc

Positions
Position Company Period
Independent Director Novavax Inc Nov. 1, 2018 -
President, Chief Executive Officer, Co-Founder, Director GlycoMimetics Inc Jan. 1, 2003 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-05-21 2021-05-19
US Novavax Inc (NVAX)
B Purchase
700 +33.3%
139.64
97,748 USD 		700 +33.3% 139.64 97,748 USD
2020-12-30 2020-12-28
PS Planned sale
84,176 -19.1%
3.91
329,128 USD 		84,176 -19.1% 3.91 329,128 USD
2019-03-28 2019-03-27
US Novavax Inc (NVAX)
B Purchase
22,000 +inf%
0.53
11,656 USD 		22,000 +inf% 0.53 11,656 USD
2019-03-28 2019-03-27
US Novavax Inc (NVAX)
B Purchase
22,000 +inf%
0.53
11,656 USD 		22,000 +inf% 0.53 11,656 USD
2019-03-28 2019-03-27
US Novavax Inc (NVAX)
B Purchase
42,000 +inf%
0.53
22,252 USD 		42,000 +inf% 0.53 22,252 USD